Intract Pharma to Present at the 22nd BIO CEO & Investor Conference

Intract Pharma CEO, Dr Bill Lindsay, will be presenting at the BIO CEO & Investor Conference in New York between 10th and 11th of February. Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies.

The presentation will focus on our lead product, INT-119, which is an oral antibody treatment for ulcerative colitis ready for Phase IIa entry after discussion with the MHRA.

When: 10:30 AM – 10:45 AM, Monday, February 10, 2020

Where: New York Marriott Marquis, 4^th Floor